These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36516106)

  • 1. Pharmacist-independent prescriber deprescribing in UK care homes: Contextual factors associated with increased activity.
    Alharthi M; Scott S; Alldred DP; Holland R; Hughes C; Birt L; Blacklock J; Bond C; Clark A; Wright D
    Br J Clin Pharmacol; 2023 Apr; 89(4):1509-1513. PubMed ID: 36516106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Process evaluation for the Care Homes Independent Pharmacist Prescriber Study (CHIPPS).
    Birt L; Dalgarno L; Wright DJ; Alharthi M; Inch J; Spargo M; Blacklock J; Poland F; Holland RC; Alldred DP; Hughes CM; Bond CM;
    BMC Health Serv Res; 2021 Oct; 21(1):1041. PubMed ID: 34600542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
    Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
    J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are residents of aged care facilities willing to have their medications deprescribed?
    Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
    Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS study.
    Bond CM; Holland R; Alldred DP; Arthur A; Barton G; Blyth A; Desborough J; Ford J; Handford C; Hill H; Hughes CM; Maskrey V; Massey K; Myint PK; Norris N; Poland FM; Shepstone L; Turner D; Zermansky A; Wright D;
    Trials; 2020 Jan; 21(1):103. PubMed ID: 31964398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
    Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
    Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
    Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
    Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
    Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
    Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home.
    Russell P; Hewage U; McDonald C; Thompson C; Woodman R; Mangoni AA
    Ther Adv Drug Saf; 2021; 12():20420986211052344. PubMed ID: 34707803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 Nov; 21(1):655. PubMed ID: 34798826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.